WallStreetZenWallStreetZen

NASDAQ: PDEX
Pro Dex Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Pro Dex earnings were $9.4M for the trailing 12 months ending Mar 31, 2025, with 391.4% growth year over year. The latest PDEX earnings report on Mar 31, 2025 announced Q1 2025 earnings of $3.3M, up 60.5% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, PDEX reported annual earnings of $2.1M, with -69.9% growth. The next PDEX earnings date is Aug 28, 2025.

PDEX past earnings growth

How has PDEX's earnings growth performed historically?

Company
391.38%
Industry
16.32%
Market
34.03%
PDEX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PDEX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PDEX's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PDEX earnings history

Current Revenue
$64.1M
Current Earnings
$9.4M
Current Profit Margin
14.6%

PDEX Return on Equity

Current Company
29.1%
Current Industry
9.7%
Current Market
31.3%
PDEX's Return on Equity (29.1%)... subscribe to Premium to read more.
High Return on Equity Performance

PDEX undefined

Current Company
16.2%
Current Industry
7.9%
PDEX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PDEX announces earnings.

PDEX undefined

Current Company
28.59%
Current Industry
10.3%
PDEX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PDEX vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PDEX$14.37M$9.37M+20.32%$2.85
KRMD-$4.42M-$5.30MN/A-$0.11
CUPR-$1.13M-$1.19MN/A-$0.07
INFU$21.19M$3.19M+6.96%$0.14
UTMD$18.75M$12.96M-0.98%$3.78
View Top Medical Stocks

PDEX earnings dates

Next earnings date
Aug 28, 2025

Pro Dex Earnings Reports & History FAQ

What were Pro Dex's earnings last quarter?

On PDEX's earnings call on Invalid Date, Pro Dex (NASDAQ: PDEX) reported Q1 2025 earnings per share (EPS) of $1.00, up 426.32% year over year. Total PDEX earnings for the quarter were $3.28 million. In the same quarter last year, Pro Dex's earnings per share (EPS) was $0.19.

If you're new to stock investing, here's how to buy Pro Dex stock.

When does Pro Dex report earnings?

The next PDEX earnings call is Invalid Date. Add PDEX to your watchlist to be reminded of Pro Dex's next earnings date.

Is Pro Dex profitable or losing money?

As of the last Pro Dex earnings report, Pro Dex is currently profitable. Pro Dex's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $9.37 million, a 358.77% increase year over year.

What was PDEX's earnings growth in the past year?

As of Pro Dex's earnings date in Invalid Date, Pro Dex's earnings has grown 391.38% year over year. This is 375.06 percentage points higher than the US Medical Instruments & Supplies industry earnings growth rate of 16.32%. PDEX earnings in the past year totalled $9.37 million.

What are Pro Dex's earnings expectations?

The current EPS estimate for Pro Dex's earnings report in Invalid Date is $0.48.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.